AM
Amarantus BioScience Holdings, Inc.
AMBS · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $36.8K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.39x
PEG N/A
P/E N/A
Growth
0 /100
Declining Rev. growth 83.17%
Book val. growth N/A
EPS growth N/A
Profitability
20 /100
Weak Op. margin 281.13%
Gross margin 100.00%
FCF margin 4,719.67%
Quality
14 /100
Poor Asset turnover 0.01x
ROIC 4.85%
ROA 46.65%
Debt
70 /100
Low Net debt/EBITDA -4.22x
Current ratio 0.00x
Debt/Assets N/A
Stability
19 /100
Unstable Profitable years 0
Beta -4.42x
EPS volatility 679.53%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre AMBS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
John Wesley Commissiong
Employees
12
Headquarters
New York City